Second, a higher proportion of corticosteroid users and type 2 diabetics among the CRP+ SSc group may also have contributed to the higher amount of inflammation and subsequently the higher ASCVD risk noted in the CRP+ SSc group. This evidence concerns the gene CRP and systemic sclerosis.